Low-dose calcium antagonists reduce energy demand and cellular damage of isolated hearts during both ischemia and reperfusion

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 360, Issue 3, 1999, Pages 287-294

  Becker, Bernhard F ^a   Möbert, Jacqueline ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Amlodipine; Barnidipine; Ca2+ channel blocker; Diltiazem; Nifedipine; Oxygen consumption; Purine catabolism; Ventricular function

Indexed keywords

ADENINE NUCLEOTIDE; AMLODIPINE; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; LACTATE DEHYDROGENASE; MEPIRODIPINE; NIFEDIPINE; PURINE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; ENERGY TRANSFER; ENZYME RELEASE; GUINEA PIG; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE FUNCTION; HEART WORK; NONHUMAN; OXYGEN CONSUMPTION; PRESSURE VOLUME CURVE; PURINE METABOLISM;

AMLODIPINE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CORONARY CIRCULATION; DILTIAZEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; GUINEA PIGS; HEART; HEMODYNAMIC PROCESSES; L-LACTATE DEHYDROGENASE; LACTIC ACID; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NIFEDIPINE; PURINES; PYRUVATES;

EID: 0032883275     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002109900053     Document Type: Article

References (36)

1. Becker BF (1993) Towards the physiological function of uric acid. Free Radic Biol Med 14:615-631
2. Becker BF, Reinholz N, Ozcelik T, Leipert B, Gerlach E (1989) Uric acid as radical scavenger and antioxidant in the heart. Pflugers Arch 415:127-135
3. Bolli R, Jeroudi BS, Patel BS, Aruoma OI, Halliwell B, Lai EK, McCay PB (1989) Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy began at the time of reperfusion-evidence that myocardial stunning is a manifestation of reperfusion injury. Circ Res 65:607-622
4. Bourdillon PDV, Poole-Wilson A (1981) Effects of ischemia and reperfusion on calcium exchange and mechanical function in isolated rabbit myocardium. Cardiovasc Res 15:121-130
5. Bravo G, Hong E, Larios F (1998) The protective effect of amlodipine on cardiac negative inotropism caused by prolonged incubation in vitro. Life Sci 63:1849-1861
6. Bünger R, Sommer O, Walter G, Stiegler H, Gerlach E (1979) Functional and metabolic features of an isolated guinea pig heart preparation performing pressure-volume work. Pflugers Arch 380:259-266
7. Ferrari R, Alfieri O, Curello S, et al (1990) Occurrence of oxidative stress during reperfusion of the human heart. Circulation 81:202-211
8. Fitzpatrick DB, Karmazyn M (1984) Comparative effects of calcium channel blocking agents and varying extracellular calcium concentration on hypoxia/reoxygenation and ischemia/repetfusion-induced cardiac injury. J Pharmacol Exp Ther 228: 761-768
9. Fox KAA, Bergmann SR, Sobel BE (1985) Pathophysiology of myocardial reperfusion. Annu Rev Med 36:125-144
10. Grinwald PM (1982) Calcium uptake during post-ischemic reperfusion in the isolated rat heart: influence of extracellular sodium. J Mol Cell Cardiol 14:359-365
11. Hearse DJ (1977) Reperfusion of the ischemic myocardium. J Mol Cell Cardiol 9:605-616
12. Heusch G (1992) Myocardial stunning: a role for calcium antagonists during ischemia? Cardiovasc Res 26:14-19
13. Jeremy RW, Koretsune Y, Marbane E, Becker LC (1992) Relation between glycolysis and calcium homeostasis in postischemic myocardium. Circ Res 70:1180-1190
14. Jong JW de (1985) Timely administration of nisoldipine essential for prevention of myocardial ATP catabolism. Eur J Pharmacol 118:53-59
15. Lee R van der, Kam KL, Pfaffendorf M, Zwieten PA van (1998) Differential time course of the vasodilator action of various calcium antagonists. Fundam Clin Pharmacol 12:607-612
16. Manning A, Singal S, Hearse DJ (1984) Reperfusion-induced arrhythmias in the rat: mechanism and prevention. J Mol Cell Cardiol 16:497-518
17. Massoudy P, Becker BF, Gerlach E (1995) Preischaemic as well as postischaemic application of a calcium antagonist affords cardioprotection in the isolated guinea pig heart. Cardiovasc Res 29:577-582
18. Motomura S, Hashimoto K (1990) Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: comparison of cardiovascular profile of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (+)-(S)-(S) conformation, with those of nifedepine and nicardipine. Jpn J Pharmacol 52:319-330
19. Nakayama K, Kashiwabara T, Yamada S, Tanaka Y (1989) Assessment in pig coronary artery of long-lasting and potent calcium antagonistic actions of the novel dihydropyridine derivative mepirodipine dihydrochloride. Arzneimittelforschimg 39:50-55
20. Nayler WJ, Buckley DJ, Leong J (1990) Calcium antagonists and the stunned myocardium. Cardioscience 1:61-64
21. Neely JR, Liebermeister H, Battersby EJ, Morgan HE (1967) Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol 212:804-814
22. Ohgoshi Y, Goto Y, Futaki S, Yaku H, Kawaguchi O, Suga H (1991) Increased oxygen cost of contractility in stunned myocardium of dog. Circ Res 69:975-988
23. Piper HM, Garcia-Dorado D, Ovize M (1998) A fresh look at reperfusion injuy. Cadiovasc Res 38:291-300
24. Przyklenk K, Kloner RA (1988) Effects of verapamil on post-ischemic "stunned" myocardium: importance of timing of treatment. J Am Coll Cardiol 11:614-623
25. Przyklenk K, Ghafari GB, Eitzman DT, Kloner RA (1989) Nifedipine administration after reperfusion ablates systolic contractile dysfunction of postischemic myocardium. J Am Coll Cardiol 13:1176-1183
26. Schwartz LM, Raschke P, Becker B, Gerlach E (1993) Adenosine contributes to neutrophil-mediated loss of myocardial function in post-ischemic guinea-pig hearts. J Mol Cell Cardiol 25:927-938
27. Silverman HS, Stern MD (1994) Ionic basis of ischaemic cardiac injury: insights from cellular studies. Cardiovasc Res 28:581-597
28. 2+ channel current by diltiazem in human mesenteric arterial myocytes. Eur J Pharmacol 30:81-90
29. Spedding M, Paoletti R (1992) III. Classification of calcium channels and the sites of action of drugs modifying channel function. Pharmacol Rev 44:363-376
30. Steenbergen C, Murphy E, Levy L, London RE (1987) Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res 60:700-707
31. Steenbergen C, Murphy E, Watts JA, London RE (1990) Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ Res 66: 135-146
32. 2+ exchange. Circ Res 65:1045-1056
33. Vander Heide RS, Schwartz LM, Reimer KA (1994) The novel calcium antagonist Ro 40-5967 limits myocardial infarct size in the dog. Cardiovasc Res 28:1526-1532
34. Villari B, Ambrosio G, Golino P, et al (1993) The effects of calcium channel antagonist treatment and oxygen radical scavenging on infarct size and the no-reflow phenomenon in reperfused hearts. Am Heart J 125:11-22
35. Watts JA, Maiorano LJ, Miorano PC (1985) Protection by verapamil of globally ischaemic rat hearts: energy preservation, a partial explanation. J Mol Cell Cardiol 17:797-804
36. Zucchi R, Limbruno U, Poddighe R, Mariani M, Ronca G (1990) Purine release from isolated rat heart: a new approach to the study of energy metabolism. J Mol Cell Cardiol 22:815-826